Dr Julius Mugwagwa

Lecturer in Development Policy and Governance


Julius Mugwagwa is a Lecturer in Development Policy and Governance. He is also the Research Impact Manager for the Strategic Research Area on International Development and Inclusive Innovation. Prior to these appointments, he was a Research Fellow in the DPP Unit and Innogen Istitute, studying innovations in health systems and biotechnology governance. He received undergraduate and postgraduate training in biological sciences, biotechnology and business administration in Zimbabwe before attaining a PhD in science, technology and innovation studies at The Open University in 2008. Julius has worked in a number of sectors including veterinary research, pharmaceutical production and quality assurance, medicines control, agricultural biotechnology research and biotechnology/biosafety governance. He is a past recipient of a Leverhulme Early Career Fellowship (2009 – 2011), and an Economic and Social Research Council (ESRC) Future Research Leaders Scheme fellowship (2013 – 2015).

Julius would welcome research students in his main area of research interest which is governance of life science innovations, looking specifically at innovations in health and agricultural biotechnology in developing countries. This includes innovations at product, organizational, regulatory/governance mechanisms and service delivery levels, the overall aim being to contribute to theoretical insights, policy and practice understandings on how best these innovations can be of benefit to user communities. Julius’ current main projects are on innovative spending in global health; role of industry associations in development and diffusion of health innovations; co-evolution of biopharma and medical device industries; and the role of standards in developing country pharmaceutical industries.

Julius teaches on the Postgraduate Development Management Programme. Within this, he co-chairs the presentation of module T879 on Conflict and Development. He also teaches on the undergraduate module TD223 International Development in a Changing World. 

Cross-national Technology Regulation in Africa

The main aims and objectives of the research fellowship were to identify and analyse evidence for existence and impact of transnational governance processes and mechanisms for biosafety and medicines control regulations in Sub-Saharan Africa.

This study confirmed the existence and persistence of an active cross-national life science technology governance agenda in Africa. The agenda is ...

Innovations for Pro-Poor Growth

A burgeoning area of interest for DPP members is the issue of how innovative activity can promote and support entrepreneurship in order to raise the income, welfare and agency of the poorest in society.  Initial ideas for the project and its conceptual base are available at www.ipg.open.ac.uk. This project currently supports three PhD students who are l...

Innovative Spending in Global Health

This project focuses on two countries in Africa (South Africa and Zimbabwe), building on the researcher and the OU DPP/INNOGEN’s past, current and on-going links with the study countries. The research targets two global health funders, the Gates Foundation and the Global Fund to Fight HIV/AIDS, TB and Malaria, looking specifically at how decisions on what health innovations to fund are arrive...

Medical devices mismatch in Southern countries

Medical devices forms key part of comprehensive healthcare all over the world. However there are key concerns regarding availability and affordibility of medical devices in the developing world. Most of the medical devices are developed and manufactured by firms based in advanced countries targetting customers in similar markets. It creates a mismatch between avalibility and needs of people in ...

Product Development Partnerships

An Innogen funded project, this project is currently in its Third Phase having first started in 2001.  This current phase of the project is concerned with questions of partnership objectives, inputs, process and outputs; and the connections between these.  We are particularly interested in knowing whether product development partnerships for new health technologies produce sustainable institu...

Unpacking the role of industry associations

This project tries to get inside the black box of innovation and politics, researching whether and in what ways biopharmaceutical associations in developing countries promote technological capabilities and effective governance of health innovation. The overarching aim is to produce a theoretically embedded, empirically-grounded, and policy relevant analysis of the role of biopharmaceutical asso...

Agro-biotechnology and Food Security

Julius Mugwagwa discusses agro-biotechnology and food security.

By working across sectors and advocating a multi-layered approach, Innogen helps countries find solutions to successfully harness and govern these new technologies. 

www.innogen.ac.uk

Blog post: Cape Times- From Exchange to Change by Julius Mugwagwa

In this blog post, Julius Mugwagwa writes about Forum 2012, the 14th edition of the Global Forum for Health Research is underway in Cape Town.

Blog post: Lost and Found in Translation by Julius Mugwagwa

In this blog Julius Mugwagwa talks about language barriers in the fieldwork process

Blogpost: Mission Possible by Julius Mugwagwa

In this new blog, Julius Mugwagwa provides reflections from a recent pilot study in South Africa and Zimbabwe for his new ESRC funded project on Innovative Spending on Global Health.

Cross-national convergence of biosafety systems in Sub-Saharan Africa

Dr. Julius Mugwagwa

This policy brief presents some key observations from an analysis of the processes towards emergence of similar cross-national biosafety systems in Sub-Saharan Africa. The promises and challenges of modern biotechnology are as wid...

Innovative spending in Global Health

Dr Julius Mugwagwa, Research Fellow at The Open University on how to get more from each dollar spent on health in development. http://dpp.open.ac.uk/people/julius-m...

His research focuses on two countries in Africa (South Africa and Zimbabwe) and on two global health funders, the Gates Foundation and the Global Fund to Fight HIV...

Local pharma in Africa: going nowhere, slowly?

Julius Mugwagwa, reflects on status of pharmaceutical industry in Africa based on his recent visit to South Africa and Zimbabwe. 

Standards and Their Role in Pharmaceutical Upgrading in Low- and Middle-Income Countries

The supply of medicines and other medical products into health delivery systems is intensively regulated and governed by strict product, process, marketing and institutional standards. The regulations and standards cover the lab to bench value chain; research and development, proof of concept, proof of efficacy, followed by authorisation and registration for production, marketing to the public ...

The Conversation: Producing medicines in Africa will only work if they can be distributed properly

Julius Mugwagwa discusses African medicine production and distribution in new editorial for The Conversation

"How African countries will meet their needs for medicines, especially medicines that big multinational companies may not consider profitable, is a daunting challenge. Aid agencies have played – and continue to play – big and decisive roles in the supply of medicines to ...

Theo Papaioannou & Julius Mugwagwa present at the Bristol International Development Conference 2014

Reflecting on theoretical, policy and practice lessons emerging from various strands of health-related research projects within Innogen, IKD and the DPP Group, Theo Papaioannou and Julius Mugwagwa gave a presentation on ‘Inclusive Innovation for Development: The Case of Health in Low and Middle Income Countries’ at the Bristol International Development Conference on March 8th at ...

Ungovernable? Biotech and its xerophytic challenges

Ungovernable? Biotech and its xerophytic challenges

Xerophytes are known to ‘rise from the dead’. They are families of plants that are adapted to living under arid desert conditions, sometimes appearing dead and good for writing-off. Yet, through their multiple anatomical and morphological adaptations to their environments, they are able to survive and continue the...

Innovative Spending in Health: Unpacking the Global Evidence

Innovative Spending in Health: Unpacking the Global Evidence

Based on findings from his 3-year ESRC-funded project, Innovative Spending in Global Health, Julius Mugwagwa analyses evidence from South Africa, the UK and Zimbabwe, before exploring the theoretical, policy and practice implications, particularly for inclusive and sustainable health.